Add to a list

Inactive Instrument

LOTUS PHARM Stock OTC Bulletin Board

LTUS

US5457151042

Pharmaceuticals

OTC Markets Traded

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	9.74M 8.55M 7.98M 7.33M 13.73M 933M 13.97M 94.27M 36.93M 461M 36.55M 35.76M 1.6B	P/E 2009	3.88x	P/E 2010	4.84x
Enterprise Value	14.38M 12.63M 11.79M 10.83M 20.29M 1.38B 20.63M 139M 54.56M 681M 53.99M 52.83M 2.36B	EV / Sales 2009	1.02x	EV / Sales 2010	0.95x
Free-Float	99%	Yield 2009 *	-	Yield 2010	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE
21-09-28	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	RE
12-05-16	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	CI
12-04-19	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	CI

12-30	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
25-10-06	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection	AQ
25-08-12	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
25-02-21	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
24-11-08	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.15%	+1.04%	+16.34%	+74.17%	49.38B
OTSUKA HOLDINGS CO., LTD.	+0.53%	+3.50%	+61.24%	+112.76%	36.35B
CIPLA LIMITED	+2.50%	+0.21%	-5.74%	+23.32%	11.87B
ZYDUS LIFESCIENCES LIMITED	-0.81%	-4.33%	+12.58%	+69.24%	11.53B
KRKA, D. D.	+0.38%	-2.06%	+34.70%	+131.86%	8.99B
ONO PHARMACEUTICAL CO., LTD.	-0.92%	-0.35%	+48.24%	-9.27%	7B
GEDEON RICHTER	-0.51%	-2.10%	+12.20%	+32.13%	6.76B
GLENMARK PHARMACEUTICALS LIMITED	-0.52%	-2.45%	+1.83%	+165.65%	6.46B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-1.32%	-11.87%	-32.46%	-0.24%	5.49B
Average	-0.06%	-0.95%	+16.55%	+66.62%	15.98B
Weighted average by Cap.	+0.21%	+0.32%	+25.56%	+78.17%

	2009	2010
Net sales	57.82M 50.79M 47.39M 43.53M 81.56M 5.54B 82.96M 560M 219M 2.74B 217M 212M 9.48B	72.7M 63.85M 59.58M 54.73M 103M 6.97B 104M 704M 276M 3.44B 273M 267M 11.91B
Net income	16.43M 14.43M 13.47M 12.37M 23.18M 1.57B 23.57M 159M 62.34M 778M 61.69M 60.35M 2.69B	14.42M 12.67M 11.82M 10.86M 20.35M 1.38B 20.69M 140M 54.72M 683M 54.15M 52.98M 2.36B
Net Debt	5.29 4.65 4.34 3.99 7.47 507.37 7.59 51.26 20.08 250.79 19.87 19.44 867.47	4.65 4.08 3.81 3.5 6.55 445.35 6.67 44.99 17.63 220.13 17.44 17.07 761.43

LOTUS PHARM Stock OTC Bulletin Board

Stocks

LTUS

US5457151042

Pharmaceuticals

Valuation: LOTUS PHARM

Latest news : LOTUS PHARM

Press Releases: LOTUS PHARM

Managers and Directors: LOTUS PHARM

Generic Pharmaceuticals

Financials

Company Profile